Increasing evidence, including our findings, indicates that visfatin functions as an inflammatory cytokine in various inflammatory conditions, such as cancer, type 2 diabetes, cardiovascular diseases, senescence/aging, periodontitis, and obesity [22,23,24,28,29,30,31,32,33,34]. The gene discussed is NAMPT; the disease is obesity due to melanocortin 4 receptor deficiency.